Cholesterol accumulates in senile plaques of Alzheimer disease patients and in transgenic APPsw mice

Takashi Mori, Daniel Paris, Terrence Town, Amyn Mohammed Rojiani, D. Larry Sparks, Anthony Delledonne, Fiona Crawford, Laila I. Abdullah, James A. Humphrey, Dennis W. Dickson, Michael J. Mullan

Research output: Contribution to journalArticle

121 Citations (Scopus)

Abstract

Mounting evidence suggests that cholesterol may contribute to the pathogenesis of Alzheimer disease (AD). We examined whether cholesterol might be present in senile plaques, a hallmark neuropathological feature of AD. We employed 2 different fluorometric-staining techniques (filipin staining and an enzymatic technique) for the determination of cholesterol in brains of postmortem confirmed AD patients and in nondemented, age-matched histopathologically normal controls. AD patient brains showed abnormal accumulation of cholesterol in congophilic/birefringent dense cores of senile plaques that was essentially absent in histopathologically normal controls. To determine whether increased senile plaque-associated cholesterol occurred generally in all plaques or was restricted to a specific subset, quantitative analysis was performed. Data indicate abnormal accumulation of cholesterol in cores of mature plaques but not in diffuse or immature plaques. Additionally, transgenic mice that overexpress the "Swedish" amyloid precursor protein (Tg APPsw, line 2576) exhibited a similar pattern of abnormal cholesterol accumulation in mature, congophilic amyloid plaques at 24 months of age that was absent in their control littermates or in 8-month-old Tg APPsw mice (an age prior to amyloid deposition). Taken together, our results imply a link between cholesterol and AD pathogenesis and suggest that cholesterol plays an important role in the formation and/or progression of senile plaques.

Original languageEnglish (US)
Pages (from-to)778-785
Number of pages8
JournalJournal of neuropathology and experimental neurology
Volume60
Issue number8
DOIs
StatePublished - Jan 1 2001
Externally publishedYes

Fingerprint

Amyloid Plaques
Transgenic Mice
Alzheimer Disease
Cholesterol
Filipin
Staining and Labeling
Amyloid beta-Protein Precursor
Brain
Amyloid

Keywords

  • Alzheimer disease
  • Cholesterol
  • Senile plaque
  • Transgenic mice

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Neurology
  • Clinical Neurology
  • Cellular and Molecular Neuroscience

Cite this

Cholesterol accumulates in senile plaques of Alzheimer disease patients and in transgenic APPsw mice. / Mori, Takashi; Paris, Daniel; Town, Terrence; Rojiani, Amyn Mohammed; Sparks, D. Larry; Delledonne, Anthony; Crawford, Fiona; Abdullah, Laila I.; Humphrey, James A.; Dickson, Dennis W.; Mullan, Michael J.

In: Journal of neuropathology and experimental neurology, Vol. 60, No. 8, 01.01.2001, p. 778-785.

Research output: Contribution to journalArticle

Mori, T, Paris, D, Town, T, Rojiani, AM, Sparks, DL, Delledonne, A, Crawford, F, Abdullah, LI, Humphrey, JA, Dickson, DW & Mullan, MJ 2001, 'Cholesterol accumulates in senile plaques of Alzheimer disease patients and in transgenic APPsw mice', Journal of neuropathology and experimental neurology, vol. 60, no. 8, pp. 778-785. https://doi.org/10.1093/jnen/60.8.778
Mori, Takashi ; Paris, Daniel ; Town, Terrence ; Rojiani, Amyn Mohammed ; Sparks, D. Larry ; Delledonne, Anthony ; Crawford, Fiona ; Abdullah, Laila I. ; Humphrey, James A. ; Dickson, Dennis W. ; Mullan, Michael J. / Cholesterol accumulates in senile plaques of Alzheimer disease patients and in transgenic APPsw mice. In: Journal of neuropathology and experimental neurology. 2001 ; Vol. 60, No. 8. pp. 778-785.
@article{6a8a044044cc438698e2ab54a8d8edd2,
title = "Cholesterol accumulates in senile plaques of Alzheimer disease patients and in transgenic APPsw mice",
abstract = "Mounting evidence suggests that cholesterol may contribute to the pathogenesis of Alzheimer disease (AD). We examined whether cholesterol might be present in senile plaques, a hallmark neuropathological feature of AD. We employed 2 different fluorometric-staining techniques (filipin staining and an enzymatic technique) for the determination of cholesterol in brains of postmortem confirmed AD patients and in nondemented, age-matched histopathologically normal controls. AD patient brains showed abnormal accumulation of cholesterol in congophilic/birefringent dense cores of senile plaques that was essentially absent in histopathologically normal controls. To determine whether increased senile plaque-associated cholesterol occurred generally in all plaques or was restricted to a specific subset, quantitative analysis was performed. Data indicate abnormal accumulation of cholesterol in cores of mature plaques but not in diffuse or immature plaques. Additionally, transgenic mice that overexpress the {"}Swedish{"} amyloid precursor protein (Tg APPsw, line 2576) exhibited a similar pattern of abnormal cholesterol accumulation in mature, congophilic amyloid plaques at 24 months of age that was absent in their control littermates or in 8-month-old Tg APPsw mice (an age prior to amyloid deposition). Taken together, our results imply a link between cholesterol and AD pathogenesis and suggest that cholesterol plays an important role in the formation and/or progression of senile plaques.",
keywords = "Alzheimer disease, Cholesterol, Senile plaque, Transgenic mice",
author = "Takashi Mori and Daniel Paris and Terrence Town and Rojiani, {Amyn Mohammed} and Sparks, {D. Larry} and Anthony Delledonne and Fiona Crawford and Abdullah, {Laila I.} and Humphrey, {James A.} and Dickson, {Dennis W.} and Mullan, {Michael J.}",
year = "2001",
month = "1",
day = "1",
doi = "10.1093/jnen/60.8.778",
language = "English (US)",
volume = "60",
pages = "778--785",
journal = "American Journal of Psychotherapy",
issn = "0002-9564",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Cholesterol accumulates in senile plaques of Alzheimer disease patients and in transgenic APPsw mice

AU - Mori, Takashi

AU - Paris, Daniel

AU - Town, Terrence

AU - Rojiani, Amyn Mohammed

AU - Sparks, D. Larry

AU - Delledonne, Anthony

AU - Crawford, Fiona

AU - Abdullah, Laila I.

AU - Humphrey, James A.

AU - Dickson, Dennis W.

AU - Mullan, Michael J.

PY - 2001/1/1

Y1 - 2001/1/1

N2 - Mounting evidence suggests that cholesterol may contribute to the pathogenesis of Alzheimer disease (AD). We examined whether cholesterol might be present in senile plaques, a hallmark neuropathological feature of AD. We employed 2 different fluorometric-staining techniques (filipin staining and an enzymatic technique) for the determination of cholesterol in brains of postmortem confirmed AD patients and in nondemented, age-matched histopathologically normal controls. AD patient brains showed abnormal accumulation of cholesterol in congophilic/birefringent dense cores of senile plaques that was essentially absent in histopathologically normal controls. To determine whether increased senile plaque-associated cholesterol occurred generally in all plaques or was restricted to a specific subset, quantitative analysis was performed. Data indicate abnormal accumulation of cholesterol in cores of mature plaques but not in diffuse or immature plaques. Additionally, transgenic mice that overexpress the "Swedish" amyloid precursor protein (Tg APPsw, line 2576) exhibited a similar pattern of abnormal cholesterol accumulation in mature, congophilic amyloid plaques at 24 months of age that was absent in their control littermates or in 8-month-old Tg APPsw mice (an age prior to amyloid deposition). Taken together, our results imply a link between cholesterol and AD pathogenesis and suggest that cholesterol plays an important role in the formation and/or progression of senile plaques.

AB - Mounting evidence suggests that cholesterol may contribute to the pathogenesis of Alzheimer disease (AD). We examined whether cholesterol might be present in senile plaques, a hallmark neuropathological feature of AD. We employed 2 different fluorometric-staining techniques (filipin staining and an enzymatic technique) for the determination of cholesterol in brains of postmortem confirmed AD patients and in nondemented, age-matched histopathologically normal controls. AD patient brains showed abnormal accumulation of cholesterol in congophilic/birefringent dense cores of senile plaques that was essentially absent in histopathologically normal controls. To determine whether increased senile plaque-associated cholesterol occurred generally in all plaques or was restricted to a specific subset, quantitative analysis was performed. Data indicate abnormal accumulation of cholesterol in cores of mature plaques but not in diffuse or immature plaques. Additionally, transgenic mice that overexpress the "Swedish" amyloid precursor protein (Tg APPsw, line 2576) exhibited a similar pattern of abnormal cholesterol accumulation in mature, congophilic amyloid plaques at 24 months of age that was absent in their control littermates or in 8-month-old Tg APPsw mice (an age prior to amyloid deposition). Taken together, our results imply a link between cholesterol and AD pathogenesis and suggest that cholesterol plays an important role in the formation and/or progression of senile plaques.

KW - Alzheimer disease

KW - Cholesterol

KW - Senile plaque

KW - Transgenic mice

UR - http://www.scopus.com/inward/record.url?scp=0034928074&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034928074&partnerID=8YFLogxK

U2 - 10.1093/jnen/60.8.778

DO - 10.1093/jnen/60.8.778

M3 - Article

VL - 60

SP - 778

EP - 785

JO - American Journal of Psychotherapy

JF - American Journal of Psychotherapy

SN - 0002-9564

IS - 8

ER -